US2017150922A1PendingUtilityA1
Methods of Enhancing Homeostatic Capacity in a Subject by Increasing Homeostatic System Component Responsiveness, and Devices for Use in Practicing the Same
Est. expiryNov 30, 2035(~9.3 yrs left)· nominal 20-yr term from priority
A61N 1/36135A61N 1/36114A61N 1/3606C12N 2750/14143C12Y 301/00A61K 38/465A61B 5/4836A61K 48/00
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of enhancing homeostatic capacity in a subject are provided. Aspects of the methods include increasing the amplitude of an input resultant response of a homeostatic system component of the subject in a manner sufficient to enhance homeostatic capacity of the subject. Also provided are devices configured for use in practicing the methods. Aspects of the invention further include methods of treating a subject for a condition via enhancement of homeostatic capacity. The methods and devices described herein find use in a variety of applications.
Claims
exact text as granted — not AI-modified1 . A method of enhancing homeostatic capacity of a subject, the method comprising:
increasing the amplitude of an input resultant response of a homeostatic system component of the subject in a manner sufficient to enhance homeostatic capacity of the subject.
2 . The method according to claim 1 , wherein the input resultant response is a chemical response.
3 . The method according to claim 1 , wherein the input resultant response is an electrical response.
4 . The method according to claim 1 , wherein the amplitude of the input resultant response is increased by 2-fold or greater.
5 . The method according to claim 1 , wherein the homeostatic system component comprises an organ or component thereof.
6 . The method according to claim 5 , wherein the homeostatic system component comprises a component of an organ.
7 . The method according to claim 6 , wherein the component comprises a cell.
8 . The method according to claim 6 , wherein the component comprises an organelle.
9 . The method according to claim 8 , wherein the organelle is a mitochondria.
10 . The method according to claim 1 , wherein the method further comprises determining a dynamic measure of homeostatic capacity for the subject.
11 . The method according to claim 10 , wherein the dynamic measure of homeostatic capacity is determined by:
obtaining dynamic biometric data from the subject; and evaluating the homeostatic capacity of the subject from the dynamic biometric data.
12 . The method according to claim 11 , wherein the dynamic biometric data comprises biometric data obtained over a period of time.
13 . The method according to claim 12 , wherein the biometric data is continuously obtained over the period of time.
14 . The method according to claim 11 , wherein the dynamic biometric data is obtained by evaluating a biometric parameter for a change in response to an applied stimulus.
15 . The method according to claim 14 , wherein the applied stimulus comprises a physical stimulus.
16 . The method according to claim 14 , wherein the applied stimulus comprises a chemical stimulus.
17 . The method according to claim 11 , wherein the dynamic biometric data is obtained by evaluating a biometric parameter for a rate of change over a period of time.
18 - 19 . (canceled)
20 . The method according to claim 1 , wherein increasing the amplitude comprises administering a therapy to the subject.
21 - 27 . (canceled)
28 . The method according to claim 1 , wherein the method comprises treating the subject for a condition.
29 . The method according to claim 28 , wherein the condition is a disease condition.
30 - 35 . (canceled)Join the waitlist — get patent alerts
Track US2017150922A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.